Atazanavir-Mepha 200mg, Kapseln

7680663390026 CH-66339 Kapseln

Associated product:

ATAZANAVIR Mepha caps 200 mg 60 pce
Atazanavir-Mepha 200mg, Kapseln
Atazanavir-Mepha 200mg, Kapseln
1 / 2
google

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/01/2024
Patient information leaflet
Français
23/01/2024
Patient information leaflet
Italien
23/01/2024
Summary of Product Characteristics
Allemand
23/01/2024
Summary of Product Characteristics
Français
23/01/2024
Summary of Product Characteristics
Italien
23/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
89.604 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 401.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/06/2019

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66339
Drug name
Atazanavir-Mepha, Kapseln
Galenic form
KAPS
ATC Code
J05AE08
Authorization status
Z
Dispensing category
A
First authorization
19/09/2017
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektionen

Package details

Description (FR)
ATAZANAVIR Mepha caps 200 mg 60 pce
Description (DE)
ATAZANAVIR Mepha Kaps 200 mg 60 Stk
Market launch
19/09/2017
Narcotic (BTM)
No

Other package sizes (2)

None
60 KAP
GTIN: None
Not in V1
ATAZANAVIR Mepha caps 300 mg bte 30 pce
30 KAP
GTIN: 7680663390033
View